David Rodman
Overview
Explore the profile of David Rodman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
724
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laffin L, Rodman D, Luther J, Vaidya A, Weir M, Rajicic N, et al.
JAMA
. 2023 Sep;
330(12):1140-1150.
PMID: 37690061
Importance: Excess aldosterone production contributes to hypertension in both classical hyperaldosteronism and obesity-associated hypertension. Therapies that reduce aldosterone synthesis may lower blood pressure. Objective: To compare the safety and efficacy...
2.
Russell S, Drack A, Cideciyan A, Jacobson S, Leroy B, Van Cauwenbergh C, et al.
Nat Med
. 2022 Apr;
28(5):1014-1021.
PMID: 35379979
CEP290-associated Leber congenital amaurosis type 10 (LCA10) is a retinal disease resulting in childhood blindness. Sepofarsen is an RNA antisense oligonucleotide targeting the c.2991+1655A>G variant in the CEP290 gene to...
3.
Boyle M, Bell S, Konstan M, McColley S, Rowe S, Rietschel E, et al.
Lancet Respir Med
. 2014 Jun;
2(7):527-38.
PMID: 24973281
Background: The phe508del CFTR mutation causes cystic fibrosis by limiting the amount of CFTR protein that reaches the epithelial cell surface. We tested combination treatment with lumacaftor, an investigational CFTR...
4.
Seliger V, Rodman D, Van Goor F, Schmelz A, Mueller P
J Cyst Fibros
. 2013 May;
12(6):706-13.
PMID: 23628510
Background: Ivacaftor, a cystic fibrosis transmembrane regulator (CFTR) potentiator, decreased sweat chloride concentrations and improved clinical measures in cystic fibrosis (CF) patients with the G551D mutation. Results: Sweat chloride measurements...
5.
Abouzgheib W, Bartter T, Kanaan R, Rodman D
J Bronchology Interv Pulmonol
. 2012 Nov;
16(2):91-4.
PMID: 23168505
Objective: We performed a retrospective review of the use of the combination of talc and doxycycline for pleurodesis in patients. Methods: There were 33 sequential cases over a 2-year period....
6.
Nicholson G, Kariyawasam H, Tan A, Hohlfeld J, Quinn D, Walker C, et al.
J Allergy Clin Immunol
. 2011 Jul;
128(4):800-807.e9.
PMID: 21719078
Background: IL-13 is a key T(H)2 cytokine that is implicated in allergic responses. Objective: We evaluated the effects of an anti-IL-13-blocking antibody compared with placebo on repeated nasal allergen challenge...
7.
Erzurum S, Rounds S, Stevens T, Aldred M, Aliotta J, Archer S, et al.
Am J Respir Crit Care Med
. 2010 Sep;
182(12):1554-62.
PMID: 20833821
The Division of Lung Diseases of the National Heart, Lung, and Blood Institute, with the Office of Rare Diseases Research, held a workshop to identify priority areas and strategic goals...
8.
Guignabert C, Izikki M, Tu L, Li Z, Zadigue P, Barlier-Mur A, et al.
Circ Res
. 2006 Apr;
98(10):1323-30.
PMID: 16614302
One intrinsic abnormality of pulmonary artery smooth muscle cells (PA-SMCs) in human idiopathic pulmonary hypertension (iPH) is an exaggerated proliferative response to internalized serotonin (5-HT) caused by increased expression of...
9.
Wallick K, Dickinson M, James D, Kugelmas M, Madinger N, Rodman D
J Cyst Fibros
. 2004 Oct;
1(2):99-101.
PMID: 15463815
We report a case of P. aeruginosa cholangitis in an adult with cystic fibrosis (CF). The patient had a past history of cholecystectomy and a new finding of intrahepatic biliary...
10.
West J, Buchholz M, Fiero A, Tada Y, Fagan K, Rodman D
J Gene Med
. 2004 Jul;
6(7):734-9.
PMID: 15241780
Background: Gene delivery to the pulmonary circulation has been studied in adult animals, but has not been extensively investigated in neonates. Methods: We tested the ability of recombinant, replication-defective adenovirus...